Prevalence of the CHEK2 R95* germline mutation

por Knappskog, Stian, Leirvaag, Beryl, Gansmo, Liv B., Romundstad, Pål, Hveem, Kristian, Vatten, Lars, Lønning, Per E.
Publicado en Hered Cancer Clin Pract (2016)

MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk

por Gansmo, Liv B., Romundstad, Pål, Birkeland, Einar, Hveem, Kristian, Vatten, Lars, Knappskog, Stian, Lønning, Per Eystein
Publicado en Cancer Med (2015)

APOBEC3A/B deletion polymorphism and cancer risk

por Gansmo, Liv B, Romundstad, Paal, Hveem, Kristian, Vatten, Lars, Nik-Zainal, Serena, Lønning, Per Eystein, Knappskog, Stian
Publicado en Carcinogenesis (2018)

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells

por Huun, Johanna, Gansmo, Liv B., Mannsåker, Bård, Iversen, Gjertrud Titlestad, Øvrebø, Jan Inge, Lønning, Per E., Knappskog, Stian
Publicado en BMC Cell Biol (2017)

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

por Gansmo, Liv B., Vatten, Lars, Romundstad, Pål, Hveem, Kristian, Ryan, Bríd M., Harris, Curtis C., Knappskog, Stian, Lønning, Per E.
Publicado en Oncotarget (2016)

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

por Huun, Johanna, Gansmo, Liv B., Mannsåker, Bård, Iversen, Gjertrud T., Sommerfelt-Pettersen, Jan, Øvrebø, Jan Inge, Lønning, Per E., Knappskog, Stian
Publicado en Transl Oncol (2017)

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

por Helwa, Reham, Gansmo, Liv B., Romundstad, Pål, Hveem, Kristian, Vatten, Lars, Ryan, Bríd M., Harris, Curtis C., Lønning, Per E., Knappskog, Stian
Publicado en Sci Rep (2016)

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

por Gansmo, Liv B., Bjørnslett, Merete, Halle, Mari Kyllesø, Salvesen, Helga B., Romundstad, Pål, Hveem, Kristian, Vatten, Lars, Dørum, Anne, Lønning, Per E., Knappskog, Stian
Publicado en BMC Cancer (2017)

The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian—but not endometrial cancer

por Gansmo, Liv B., Bjørnslett, Merete, Halle, Mari Kyllesø, Salvesen, Helga B., Dørum, Anne, Birkeland, Einar, Hveem, Kristian, Romundstad, Pål, Vatten, Lars, Lønning, Per Eystein, Knappskog, Stian
Publicado en Tumour Biol (2016)

Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer

por Yang, Sujuan, Che, Sara P. Y., Kurywchak, Paul, Tavormina, Jena L., Gansmo, Liv B., Correa de Sampaio, Pedro, Tachezy, Michael, Bockhorn, Maximilian, Gebauer, Florian, Haltom, Amanda R., Melo, Sonia A., LeBleu, Valerie S., Kalluri, Raghu
Publicado en Cancer Biol Ther (2017)

MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk

por Knappskog, Stian, Gansmo, Liv B., Romundstad, Pål, Bjørnslett, Merete, Trovik, Jone, Sommerfelt-Pettersen, Jan, Løkkevik, Erik, Tollenaar, Rob A. E. M., Seynaeve, Caroline, Devilee, Peter, Salvesen, Helga B., Dørum, Anne, Hveem, Kristian, Vatten, Lars, Lønning, Per E.
Publicado 2012

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

por Knappskog, Stian, Gansmo, Liv B., Dibirova, Khadizha, Metspalu, Andres, Cybulski, Cezary, Peterlongo, Paolo, Aaltonen, Lauri, Vatten, Lars, Romundstad, Pål, Hveem, Kristian, Devilee, Peter, Evans, Gareth D., Lin, Dongxin, Camp, Guy Van, Manolopoulos, Vangelis G., Osorio, Ana, Milani, Lili, Ozcelik, Tayfun, Zalloua, Pierre, Mouzaya, Francis, Bliznetz, Elena, Balanovska, Elena, Pocheshkova, Elvira, Kučinskas, Vaidutis, Atramentova, Lubov, Nymadawa, Pagbajabyn, Titov, Konstantin, Lavryashina, Maria, Yusupov, Yuldash, Bogdanova, Natalia, Koshel, Sergey, Zamora, Jorge, Wedge, David C., Charlesworth, Deborah, Dörk, Thilo, Balanovsky, Oleg, Lønning, Per E.
Publicado en Oncotarget (2014)